19410

543213

ROSSARI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ROSSARI BIOTECH LIMITED Share Price Today

ROSSARI BIOTECH LIMITED is currently trading at ₹503.95, up by ₹15.3 from the previous close. The stock touched an intraday high of ₹512.00 and a low of ₹490.60 during the latest trading session. Over the past one year, ROSSARI BIOTECH LIMITED has delivered a loss of 29.0%, while the stock has declined 6.99% in the last one month.

ROSSARI BIOTECH LIMITED performance

Today’s low Today’s high
₹ 490.60 ₹ 512.00
₹ 500.30
52 week low 52 week high
₹ 375.00 ₹ 766.00
₹ 500.30
Open Price ₹ 498.00
Prev. Close ₹ 488.65
Volume (Shares) 90434.00
Total traded value ₹ 452.44
Upper Circuit ₹ 586.35
Lower Circuit ₹ 390.95
info

Investment Returns

Over 1 Month -6.99% Over 3 Months 5.72% Over 6 Months -16.39% Over 1 Year -29.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ROSSARI BIOTECH LIMITED fundamentals


  • Market cap (Cr) 2,771.00
  • P/E Ratio (TTM) 18.96
  • Beta 1.07
  • Book Value / share 219.97
  • Return on equity 11.26%
  • EPS (TTM) 25.79
  • Dividend yield 0.10%
  • Net profit/quarter (Cr) 54.73
info icon alternate text
  • Market cap (Cr) 2,775.10
  • P/E Ratio (TTM) 18.96
  • Beta 0.96
  • Book Value / share 219.97
  • Return on equity 11.26%
  • EPS (TTM) 25.79
  • Dividend yield 0.10%
  • Net profit/quarter (Cr) 54.73
info icon alternate text

ROSSARI BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 516.14
Operating Expense 465.32
Net Profit 54.73
Net Profit Margin (%) 10.60
Earnings Per Share (EPS) 9.88
EBITDA 86.33
Effective Tax Rate (%) 25.58
Particulars DEC 2025 (Values in Cr)
Revenue 450.66
Operating Expense 411.70
Net Profit 30.63
Net Profit Margin (%) 6.79
Earnings Per Share (EPS) 5.53
EBITDA 51.52
Effective Tax Rate (%) 23.61
Particulars SEP 2025 (Values in Cr)
Revenue 419.51
Operating Expense 378.93
Net Profit 31.25
Net Profit Margin (%) 7.44
Earnings Per Share (EPS) 5.64
EBITDA 51.80
Effective Tax Rate (%) 25.54
Particulars JUN 2025 (Values in Cr)
Revenue 365.76
Operating Expense 332.04
Net Profit 26.23
Net Profit Margin (%) 7.17
Earnings Per Share (EPS) 4.74
EBITDA 45.68
Effective Tax Rate (%) 25.98
Particulars MAR 2025 (Values in Cr)
Revenue 426.65
Operating Expense 385.20
Net Profit 32.36
Net Profit Margin (%) 7.58
Earnings Per Share (EPS) 5.85
EBITDA 54.59
Effective Tax Rate (%) 26.19
Particulars MAR 2026 (Values in Cr)
Revenue 1752.07
Operating Expense 1588.01
Net Profit 142.84
Net Profit Margin (%) 8.15
Earnings Per Share (EPS) 25.79
EBITDA 235.34
Effective Tax Rate (%) 25.23
Particulars MAR 2025 (Values in Cr)
Revenue 1431.63
Operating Expense 1282.65
Net Profit 114.74
Net Profit Margin (%) 8.01
Earnings Per Share (EPS) 20.75
EBITDA 191.97
Effective Tax Rate (%) 25.83
Particulars MAR 2024 (Values in Cr)
Revenue 1202.91
Operating Expense 1075.55
Net Profit 99.65
Net Profit Margin (%) 8.28
Earnings Per Share (EPS) 18.05
EBITDA 168.01
Effective Tax Rate (%) 25.71
Particulars MAR 2023 (Values in Cr)
Revenue 975.17
Operating Expense 883.13
Net Profit 71.39
Net Profit Margin (%) 7.32
Earnings Per Share (EPS) 12.95
EBITDA 126.25
Effective Tax Rate (%) 25.36
Particulars MAR 2022 (Values in Cr)
Revenue 1072.84
Operating Expense 978.87
Net Profit 79.47
Net Profit Margin (%) 7.40
Earnings Per Share (EPS) 14.49
EBITDA 135.50
Effective Tax Rate (%) 25.50
Particulars MAR 2025 (Values in Cr)
Book Value / Share 214.12
ROE % 12.21
ROCE % 15.74
Total Debt to Total Equity 0.15
EBITDA Margin 12.98
Particulars MAR 2024 (Values in Cr)
Book Value / Share 189.65
ROE % 13.32
ROCE % 18.16
Total Debt to Total Equity 0.10
EBITDA Margin 14.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 165.93
ROE % 12.47
ROCE % 17.52
Total Debt to Total Equity 0.05
EBITDA Margin 13.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 146.25
ROE % 16.10
ROCE % 22.71
Total Debt to Total Equity 0.01
EBITDA Margin 13.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.72
ROE % 23.02
ROCE % 28.71
Total Debt to Total Equity 0.10
EBITDA Margin 18.70
Particulars MAR 2025 (Values in Cr)
Book Value / Share 194.56
ROE % 11.26
ROCE % 15.21
Total Debt to Total Equity 0.06
EBITDA Margin 13.41
Particulars MAR 2024 (Values in Cr)
Book Value / Share 173.83
ROE % 10.96
ROCE % 14.71
Total Debt to Total Equity 0.07
EBITDA Margin 13.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 155.69
ROE % 8.69
ROCE % 11.72
Total Debt to Total Equity 0.04
EBITDA Margin 12.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 142.50
ROE % 13.37
ROCE % 18.34
Total Debt to Total Equity 0.00
EBITDA Margin 12.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 77.88
ROE % 23.00
ROCE % 28.78
Total Debt to Total Equity 0.10
EBITDA Margin 18.98
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 57.16
Total Assets 1896.18
Total Liabilities 1896.18
Total Equity 1185.44
Share Outstanding 5
Price to Book Ratio 3.10
Return on Assets (%) 7.19
Return on Capital (%) 9.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.21
Total Assets 1572.15
Total Liabilities 1572.15
Total Equity 1047.72
Share Outstanding 5
Price to Book Ratio 3.88
Return on Assets (%) 8.31
Return on Capital (%) 11.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 123.93
Total Assets 1367.56
Total Liabilities 1367.56
Total Equity 915.16
Share Outstanding 5
Price to Book Ratio 3.82
Return on Assets (%) 7.84
Return on Capital (%) 10.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 52.35
Total Assets 1256.72
Total Liabilities 1256.72
Total Equity 805.16
Share Outstanding 5
Price to Book Ratio 6.41
Return on Assets (%) 7.77
Return on Capital (%) 12.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 88.26
Total Assets 561.34
Total Liabilities 561.34
Total Equity 408.77
Share Outstanding 5
Price to Book Ratio 13.32
Return on Assets (%) 14.29
Return on Capital (%) 19.62
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 16.01
Total Assets 1450.92
Total Liabilities 1450.92
Total Equity 1077.17
Share Outstanding 5
Price to Book Ratio 3.10
Return on Assets (%) 7.90
Return on Capital (%) 10.36
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.67
Total Assets 1281.16
Total Liabilities 1281.16
Total Equity 960.34
Share Outstanding 5
Price to Book Ratio 3.88
Return on Assets (%) 7.77
Return on Capital (%) 9.81
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 80.27
Total Assets 1125.66
Total Liabilities 1125.66
Total Equity 858.69
Share Outstanding 5
Price to Book Ratio 3.82
Return on Assets (%) 6.34
Return on Capital (%) 7.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 34.81
Total Assets 925.93
Total Liabilities 925.93
Total Equity 784.52
Share Outstanding 5
Price to Book Ratio 6.41
Return on Assets (%) 8.58
Return on Capital (%) 10.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 85.98
Total Assets 544.35
Total Liabilities 544.35
Total Equity 404.44
Share Outstanding 5
Price to Book Ratio 13.32
Return on Assets (%) 14.53
Return on Capital (%) 19.56
Particulars MAR 2025 (Values in Cr)
Net Income 185.18
Cash from Operations 196.64
Cash from Investing -183.69
Cash from Financing 64.90
Net change in Cash 18.64
Free Cash Flow 355.15
Particulars MAR 2024 (Values in Cr)
Net Income 177.61
Cash from Operations 97.13
Cash from Investing -103.21
Cash from Financing 16.18
Net change in Cash -43.77
Free Cash Flow 228.41
Particulars MAR 2023 (Values in Cr)
Net Income 144.21
Cash from Operations 199.33
Cash from Investing -180.89
Cash from Financing 60.85
Net change in Cash 31.51
Free Cash Flow 232.21
Particulars MAR 2022 (Values in Cr)
Net Income 136.27
Cash from Operations 79.48
Cash from Investing -298.87
Cash from Financing 291.79
Net change in Cash 22.26
Free Cash Flow 117.70
Particulars MAR 2021 (Values in Cr)
Net Income 106.83
Cash from Operations 79.11
Cash from Investing -37.17
Cash from Financing -24.59
Net change in Cash -14.00
Free Cash Flow 137.19
Particulars MAR 2025 (Values in Cr)
Net Income 154.70
Cash from Operations 131.47
Cash from Investing -69.91
Cash from Financing -32.27
Net change in Cash -9.99
Free Cash Flow 184.44
Particulars MAR 2024 (Values in Cr)
Net Income 134.13
Cash from Operations 109.41
Cash from Investing -69.54
Cash from Financing -22.09
Net change in Cash -17.72
Free Cash Flow 161.24
Particulars MAR 2023 (Values in Cr)
Net Income 95.64
Cash from Operations 137.94
Cash from Investing -160.58
Cash from Financing 61.20
Net change in Cash 13.55
Free Cash Flow 159.40
Particulars MAR 2022 (Values in Cr)
Net Income 106.68
Cash from Operations 57.34
Cash from Investing -318.11
Cash from Financing 296.91
Net change in Cash 11.91
Free Cash Flow 89.79
Particulars MAR 2021 (Values in Cr)
Net Income 105.99
Cash from Operations 83.02
Cash from Investing -36.99
Cash from Financing -29.45
Net change in Cash -14.36
Free Cash Flow 141.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ATUL LTD. 6499.35 28.23 3.07 19135.23 5563.00 7793.00
BASF INDIA LTD 3253.95 33.84 3.55 14084.93 2906.90 5251.00
ORIENTAL AROMATICS LTD 323.40 330.00 1.63 1088.36 227.05 421.60
DEEPAK FERTILISERS & PETROCHEM 1503.25 25.74 2.77 18976.70 865.45 1776.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ADVANCE PETROCHEMICALS LTD. 270.70 0.00 6.13 24.36 97.60 320.75
ATUL LTD. 6499.35 32.16 3.15 19135.23 5563.00 7793.00
BASF INDIA LTD 3253.95 33.78 3.54 14084.93 2906.90 5251.00
ORIENTAL AROMATICS LTD 323.40 43.06 1.55 1088.36 227.05 421.60

ROSSARI BIOTECH LIMITED shareholding pattern

Holding
11.46%
68.15%
2.18%
18.2%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

ROSSARI BIOTECH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
500.25 2.37 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 507.80
  • 26 Days 513.20
  • 10 Days 514.80
  • 50 Days 505.50
  • 12 Days 515.80
  • 100 Days 513.40
  • 20 Days 515.50
  • 200 Days 553.70
493.78 PIVOT
First Support 477.17 First Resistance 505.27 Second Support 465.68 Second Resistance 521.88 Third Support 449.07 Third Resistance 533.37
RSI 41.37 ADX 20.16 MACD 2.67 Williams % R -90.96 Commodity Channel Index (CCI) -157.66
Date 2026-06-11 Week 27229.00 Same Day 46900.00 Month 49631.00
1 Year 1.08 3 Year 0.75
Over 1 Month
-6.99% down
Over 1 Year
-29.00% down
Over 3 Months
5.72% down
Over 3 Years
-16.61% down
Over 6 Months
-16.39% down
Over 5 Years
-16.99% down

ROSSARI BIOTECH LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
20 Jun 2025 0.5 Final 20 Jun 2025 Equity shares
16 Aug 2024 0.5 Final 16 Aug 2024 Equity shares
24 May 2023 0.5 Final 24 May 2023 Equity shares
07 Jul 2022 0.5 Final 08 Jul 2022 Equity shares
08 Sep 2021 0.5 Final 11 Sep 2021 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
20 Jun 2025 0.5 Final 20 Jun 2025 Equity shares
16 Aug 2024 0.5 Final 16 Aug 2024 Equity shares
24 May 2023 0.5 Final 24 May 2023 Equity shares
07 Jul 2022 0.5 Final 08 Jul 2022 Equity shares
08 Sep 2021 0.5 Final 11 Sep 2021 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Rossari Biotech Ltd?

Answer Field

Rossari Biotech Ltd share price is for NSE ₹ 503.95 & for BSE ₹ 502.35 as on Jun 12 2026 03:30 PM.

What is the Market Cap of Rossari Biotech Ltd Share?

Answer Field

The market cap of Rossari Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 12 2026 03:30 PM.

What is the 52 Week High and Low of Rossari Biotech Ltd?

Answer Field

The 52 Week High and Low of Rossari Biotech Ltd for NSE is ₹ 766.00 and ₹ 375.00 and for BSE is ₹ 767.55 and ₹ 372.90.

What is 1 year return for Rossari Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -29.00%.

What is the P/E Ratio of Rossari Biotech Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM the price-to-earnings (PE) ratio for Rossari Biotech Ltd share is 18.96.

What is the PB ratio of Rossari Biotech Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM, the price-to-book (PB) ratio for Rossari Biotech Ltd share is 219.97.

How to Buy Rossari Biotech Ltd Share?

Answer Field

You can trade in Rossari Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Rossari Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Rossari Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Rossari Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|